Testing effectiveness (Phase 2)Looking for participantsNCT07562581
What this trial is testing
Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
Who this might be right for
Non-small Cell Lung CanerKRAS-mutatedMetastasis+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 48